Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
Open Access
Abstract
Objectives: To assess the clinical and biochemical factors associated with inter-individual variation in susceptibility to coronary artery disease (CAD) in treated heterozygous familial hypercholesterolaemia. Design: A cross sectional study was conducted of 410 patients recruited from six lipid clinics in the UK. Results: CAD was documented in 104 of the 211 men and in 55 of the 199 women with mean ages of onset of 43.1 and 46.5 years, respectively. CAD was significantly more common in men (49% v 28%, p < 0.001) and in patients who had smoked cigarettes versus patients who had never smoked (51% v 28%, p < 0.001). After adjusting for age, sex, and current smoking status, there were no significant differences between patients with or without CAD in lipoprotein(a), homocysteine, fibrinogen, plasminogen activator inhibitor-1, white blood cell count, body mass index, glucose, triglyceride or total cholesterol. However, high density lipoprotein (HDL) cholesterol concentrations were significantly lower in those with CAD (6%, 95% confidence interval (CI) 1% to 11%, p = 0.03) and this difference was greater in women than men (12% v 2%, p = 0.041). Conclusions: These results indicate that emerging coronary risk factors appear not to be associated with CAD in adults with treated familial hypercholesterolaemia, but the strong association with smoking suggests that patients should be identified early in childhood and discouraged from ever starting to smoke.Keywords
This publication has 41 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemiaEuropean Heart Journal, 2001
- Outcome of case finding among relatives of patients with known heterozygous familialBMJ, 2000
- Familial Hypercholesterolemia in the Finnish North KareliaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Carotid intima-media thickness in young patients with familial hypercholesterolaemia.Heart, 1996
- Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Heterozygous familial hypercholesterolemiaAtherosclerosis, 1979
- Coronary Artery Disease in 116 Kindred with Familial Type II HyperlipoproteinemiaCirculation, 1974